B-cell malignancies

COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...

BASEL, Switzerland, June 8, 2026 Roche announced a global licensing and collaboration agreement with Nurix Therapeutics to co-develop and...

CAMBRIDGE, Mass., April 2, 2026 AvenCell Therapeutics, Inc. has achieved a major regulatory milestone with both the U.S. FDA...